Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2025-05-06 2025-05-06
Drug Identification Number 02541602 02541602
Brand name QUILLIVANT ER CHEWABLE TABLETS QUILLIVANT ER CHEWABLE TABLETS
Common or Proper name METHYLPHENIDATE METHYLPHENIDATE
Company Name KYE PHARMACEUTICALS INC. KYE PHARMACEUTICALS INC.
Ingredients METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) TABLET (CHEWABLE, EXTENDED-RELEASE) TABLET (CHEWABLE, EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 100 tablets 100 tablet bottles
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2025-05-19 2025-05-19
Actual start date
Estimated end date 2025-06-09 2025-06-09
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments